On a mission to block transmission by Ross, Amanda & Brancucci,  Nicolas MB
MALARIA
On a mission to block
transmission
The controlled infection of volunteers with Plasmodium falciparum
parasites could provide a platform to evaluate new drugs and vaccines
aimed at blocking malaria transmission.
AMANDA ROSS AND NICOLAS MB BRANCUCCI
L
ife inside a human host is fraught with
danger. Plasmodium falciparum
malaria parasites need to be highly
adapted to compete for resources and to take
their chances with the immune system. The same
degree of specialization is needed to survive
inside the mosquito, and for the transitions from
human to mosquito and vice versa. These seem-
ingly incompatible needs are met by a life cycle
that involves morphing into a series of different
forms.
Under the microscope, a blood sample may
reveal different stages of the parasite: asexual
parasites that replicate and prolong the infec-
tion, and sexual stages called gametocytes, the
form that transmits the infection from human to
mosquito. Both male and female gametocytes
arise when a small proportion of asexual para-
sites stop replication and commit to sexual
development instead. After maturation they are
either taken up by a feeding mosquito or die.
Sex and transmission are inextricably linked. Fer-
tilization occurs inside the mosquito gut within
an hour of feeding and leads to several develop-
mental phases inside the insect vector, after
which parasites are ready to infect a new human
host (Sinden, 2017).
Most licensed antimalarial drugs target the
asexual forms of the parasite. These stages are
the most abundant and cause the symptoms of
malaria (Sinden, 2017; Nilsson et al., 2015). As
the burden of disease has declined in many
regions and the focus is shifting towards malaria
elimination, the searchlight beam now falls onto
other stages. On paper, gametocytes are a
good target to break the circle of transmission:
they are the only form capable of infecting mos-
quitoes and their low number creates a popula-
tion bottleneck.
However, efforts to introduce new drugs and
vaccines that target gametocytes and prevent
malaria transmission face an obstacle: there is no
method to directly evaluate their success in
humans. Clinical studies in malaria patients can
demonstrate the effect of drugs on asexual para-
sites, but often fail to capture the dynamics of
gametocytes for simple reasons. Gametocytes
generally occur at very low densities and are
often missed by standard detection
methods. They sequester away from the blood
stream for eight to twelve days as they mature,
and often are not seen at the time of illness.
Consequently, the evaluation of drugs is mostly
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limited to unnatural conditions, such as measur-
ing gametocyte densities in cell cultures or artifi-
cially feeding blood infected with
gametocytes to mosquitoes.
Now, in eLife, Robert Sauerwein, Teun Bou-
sema and colleagues – including Isaie Reuling as
first author – report a promising method to fill
this void (Reuling et al., 2018). The researchers
– who are based at the Radboud University
Medical Center and other universities and non-
profit organizations in the UK, United States,
Australia and the Netherlands – drew on recent
scientific developments in sensitive molecular
diagnostic methods, the stage-specificity of
drugs and the resurgence of interest in human
challenge studies (Farid et al., 2017;
Stanisic et al., 2018; Stone et al., 2017).
Reuling et al. deliberately infected volunteers
with P. falciparum using Anopheles mosquitoes.
The ensuing asexual parasite densities were con-
trolled and eventually cleared using different
drugs while allowing the gametocytes to con-
tinue development under safe conditions. All of
the volunteers yielded circulating gametocytes.
A crucial question is how well this method of
generating gametocytes in humans would work
to evaluate a compound that blocks transmis-
sion. Effects on gametocyte densities can be
shown (Collins et al., 2018). However, such den-
sities are only loosely related to transmission
success (Churcher et al., 2013). The most
relevant measure would be whether or not feed-
ing mosquitoes become infected. Reuling et al.
observed that the low gametocyte numbers in
the volunteers only sporadically infected mosqui-
toes, and are aware that this renders conclusions
about transmission-blocking activity impossible.
Changing certain elements of the study
setup, for example using different drugs, treat-
ment doses, P. falciparum laboratory strains or
mosquito species, may overcome this issue.
Another possibility could be to enhance gameto-
cyte production by inducing sexual commitment.
However, we are only beginning to understand
the triggers for this process (Bechtsi and
Waters, 2017). Recently, a human lipid was
shown to inhibit sexual commitment
(Brancucci et al., 2017). Interfering with the
underlying regulatory pathway could be
exploited in the future. But regardless of how
these problems are tackled, questions of how
well the system translates into real life settings
would need to be addressed carefully.
A side-effect of piloting the method of con-
trolled human infection is the insight into the
secret lives of gametocytes. Previously, the most
detailed studies of gametocyte dynamics had
been made when deliberate infections were
used to treat neurosyphilis patients at a time
before antibiotics were available (Snounou and
Pe´rignon, 2013). By using highly sensitive and
sex-specific detection methods, Reuling et al.
Figure 1. Red blood cells infected with Plasmodium falciparum parasites. Malaria parasites have a complex life
cycle and different forms of the parasites can be found in the blood. This scanning electron micrograph shows red
blood cells infected with the parasite: an asexual stage on the left and a mature gametocyte on the right. Only the
gametocytes can infect mosquitoes.
Ó Brand, 2018. Image courtesy of Franc¸oise Brand, Swiss Tropical and Public Health Institute and University of
Basel. Published under a CC BY 4.0 license. http://creativecommons.org/licenses/by/4.0/
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add to the pool of knowledge and provide evi-
dence that mature male and female gameto-
cytes first appear in the blood at different times,
and that female gametocytes circulate in the
blood for longer. The early appearance of
mature gametocytes in the peripheral blood of
the volunteers further suggests that a fraction of
the first wave of parasites entering the blood
stream can already be sexually committed.
A system to evaluate potential transmission-
blocking strategies in vivo is hugely appealing.
In future, an optimized setup that can achieve
a higher proportion of infected mosquitoes may
help to discover new ways to prevent malaria
transmission. The work of Reuling et al. has
opened a door.
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